Before Changing Lithium, Check the Clock

The following scene is a fictional composite, not an account of an actual patient.

A psychiatrist opens a lithium result before a follow-up visit. The concentration is lower than expected. The medication list shows the prescribed dose, and the laboratory records when blood was collected. Neither tells the clinician when the patient last took lithium.

The result is real. Its place in the dosing interval is unknown.

Before deciding that treatment is inadequate, or that the patient did not follow the plan, reconstruct what happened between the last dose and the blood draw.

Section 2.3 of the cited U.S. prescribing information describes sampling as "immediately prior to the next dose when lithium concentrations are relatively stable (i.e., 12 hours after the previous dose)." It also requires clinical and laboratory assessment together.

For twice-daily doses taken 12 hours apart, those descriptions coincide. For doses taken once every 24 hours, they do not: a 12-hour sample and a sample just before the next dose are about 12 hours apart. The note should record which interval the sample represents. The arithmetic explains the ambiguity; the sampling plan still needs to match the prescribed formulation, schedule and clinical guidance.

The practical task is to establish the actual dose time and actual collection time. A prescription instruction is not evidence of when a dose was taken. A morning appointment is not evidence of a 12-hour interval.

For routine monitoring, ask the patient to reconstruct the relevant evening or morning, then compare that account with the laboratory timestamp. When the dose time cannot be established, document that uncertainty and decide whether another sample is needed before using the result to change treatment.

Section 12.3 describes lithium absorption and elimination. After absorption, with no intervening dose and otherwise comparable conditions, a later sample can show a lower concentration. The prescribing concern follows from that pharmacology: mistaking a late sample for a 12-hour result could prompt an unnecessary dose increase and raise toxicity risk.

A correctly timed sample still needs context. Section 2.3 calls for monitoring after dose or concurrent-medication changes and during concomitant illness. Section 5.1 identifies impaired renal function, dehydration and interacting medicines among toxicity risk factors. In some patients abnormally sensitive to lithium, toxicity can occur at concentrations ordinarily considered therapeutic.

What has the patient actually taken? What has changed since the last assessment? How are they doing clinically? Does the result fit that account?

Timing is one explanation to investigate alongside symptoms and recent changes. Target concentrations and dose decisions require the patient's treatment phase, clinical assessment and applicable prescribing guidance.

Routine sampling instructions must not become a reason to wait when toxicity is suspected.

The NHS Specialist Pharmacy Service advises an immediate urgent lithium level and specialist advice when lithium toxicity is suspected. For patients with symptoms of toxicity, it advises withholding lithium, obtaining urgent lithium and urea/electrolyte tests, and seeking specialist advice. Its symptom examples include vomiting, tremor and mental-state changes. This is UK professional guidance; clinical judgment determines referral urgency and care setting.

A patient who is confused, unwell or developing concerning neurologic symptoms needs prompt assessment. An apparently reassuring concentration cannot overrule that assessment.

The clock helps explain the number. It cannot certify that the patient is safe.

In the fictional routine encounter, the useful outcome is a clarified sampling plan. The clinician and patient can work backward from an achievable collection appointment, with explicit instructions tied to the prescribed regimen. Agree what last-dose information to bring and whom to contact if the planned timing cannot be followed.

When the next result arrives, the dose time, collection time and elapsed interval should travel with it.

Source note: The regimen comparison is arithmetic; the potential prescribing error and documentation suggestions are editorial synthesis informed by these sources. Neither source quantifies harm from the timing error described here.

Educational Disclaimer: The Psychiatric Record provides general educational information for psychiatric and mental-health professionals. Content does not constitute medical, legal, regulatory, compliance, billing, or other professional advice; does not establish a standard of care; and is not a substitute for independent professional judgment. Appropriate assessment and treatment depend on the individual, setting, and current authoritative guidance. This article does not provide an individualized lithium dosing or monitoring plan; suspected toxicity requires prompt clinical assessment. The clinical scene is a fictional composite; no individual is depicted.